Lungs News and Research

RSS

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Researchers at the Translational Genomics Research Institute have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.

5 Mar 2014

Cancer contributes to schizophrenia mortality

Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.

4 Mar 2014

GTx provides clinical updates, reports financial results for fourth quarter and full year 2013

GTx, Inc. today provided a Company update and reported financial results for the fourth quarter and full year 2013.

4 Mar 2014

Plymouth University doctor wins national award for animal testing alternative

Dr. Gyorgy Fejer from Plymouth University School of Biomedical and Healthcare Sciences has received a national award for his work developing the lab-based creation of a type of mouse cell line which could be used in place of live animals for research related to infectious diseases.

4 Mar 2014

Blocking myoferlin gene can reduce breast cancer cell migration

New research suggests that a protein only recently linked to cancer has a significant effect on the risk that breast cancer will spread, and that lowering the protein's level in cell cultures and mice reduces chances for the disease to extend beyond the initial tumor.

4 Mar 2014

Loyola physician sheds light on common and painful viral infection, shingles

Shingles is a painful viral infection that affects almost one million people worldwide and 30 percent of Americans every year.

4 Mar 2014

Research provides insight into biologic mechanisms that individual cancer cells use to metastasize to brain

New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

4 Mar 2014

Viewpoints: Frightening seniors; regulating e-cigarettes; waiting for black lung drugs

The Obama administration's proposed cuts to Medicare Advantage plans -; the private insurance plans that cover almost 30 percent of all Medicare beneficiaries -; are fair and reasonable. As it happens, they are also mandated by law. Yet Republicans, sensing a campaign issue, are telling older and disabled Americans that the administration is "raiding Medicare Advantage to pay for Obamacare." The health insurance industry, for its part, is warning that enrollees will suffer higher premiums, lower benefits and fewer choices among doctors if the cuts go into force (3/1).

4 Mar 2014

LUNGevity Foundation awarded grant to develop educational materials on immuno-oncology

LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers Squibb for the development of educational materials on immuno-oncology. Progress in understanding lung cancer and treatment approaches has accelerated dramatically in the past several years after many slow decades.

4 Mar 2014

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting , San Diego, California, USA on March 1st.

3 Mar 2014

Microencapsulated drug delivery may soon revolutionize cancer treatment

Invasive and systemic cancer treatment is a necessary evil for many people with the devastating diagnosis. These patients endure therapies with ravaging side effects, including nausea, immune suppression, hair loss and even organ failure, in hopes of eradicating cancerous tissues in the body.

3 Mar 2014

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a "cytokine storm"—that can both sicken and kill patients who are infected with certain strains of flu virus.

3 Mar 2014

Deficient hygiene routines make it difficult to eradicate multi-resistant bacterium

A previously unknown multi-resistant bacterium has been sticking around at a Swedish University Hospital for ten years.

3 Mar 2014

Sunburn causes melanoma through direct and indirect processes

Melanoma is particularly dangerous because it can form metastases in vital organs such as the lungs, liver or brain. UV radiation is considered to be the most significant triggering factor.

3 Mar 2014

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities.

3 Mar 2014

Scientists find certain species of nontuberculous mycobacteria in water that cause infection in humans

Brisbane's water supply has been found to contain disease carrying bugs which can be directly linked to infections in some patients, according to a new study by QUT.

3 Mar 2014

Scientist talks tax and price polices for tobacco

Scientist at the International Agency for Research on Cancer (IARC) talks tax and price polices for tobacco. The International Agency for Research on Cancer (IARC) has produced a handbook detailing the scientific evidence on tobacco pricing and tobacco control entitled: Effectiveness of Tax and Price Policies for Tobacco Control.

3 Mar 2014

NCI scientist recognized for AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention

The American Association for Cancer Research (AACR) and the American Cancer Society will recognize Curtis C. Harris, M.D., with the 23rd Annual AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

3 Mar 2014

Plasma microRNA test boosts lung cancer screening

The ability to screen for lung cancer is improved by the development of a plasma 24-microRNA signature classifier, research suggests.

28 Feb 2014

Dyax reports total revenues of $16.9 million for fourth quarter 2013

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2013.

28 Feb 2014

Lungs News and Research

Mcl-1 protein enables NSCLC to survive radiation and drug treatments

Cancer contributes to schizophrenia mortality

GTx provides clinical updates, reports financial results for fourth quarter and full year 2013

Plymouth University doctor wins national award for animal testing alternative

Blocking myoferlin gene can reduce breast cancer cell migration

Loyola physician sheds light on common and painful viral infection, shingles

Research provides insight into biologic mechanisms that individual cancer cells use to metastasize to brain

Viewpoints: Frightening seniors; regulating e-cigarettes; waiting for black lung drugs

LUNGevity Foundation awarded grant to develop educational materials on immuno-oncology

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Microencapsulated drug delivery may soon revolutionize cancer treatment

Scientists map key elements of immune overreaction triggered by influenza virus infection

Deficient hygiene routines make it difficult to eradicate multi-resistant bacterium

Sunburn causes melanoma through direct and indirect processes

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

Scientists find certain species of nontuberculous mycobacteria in water that cause infection in humans

Scientist talks tax and price polices for tobacco

NCI scientist recognized for AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention

Plasma microRNA test boosts lung cancer screening

Dyax reports total revenues of $16.9 million for fourth quarter 2013

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News